- Nachrichtendetail
-
29.04.2024 15:04:23 - dpa-AFX: *FDA OKS ABBOTT'S ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM FOR CHRONIC LIMB-THREATENING ISCHEMIA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Abbott Laboratories | 850103 | NYSE | 104,132 | 11.07.24 21:20:34 | +1,082 | +1,05% | 104,130 | 104,150 | 101,420 | 103,050 |
